Among the 95 ESCC cases, 18 cases (18.9%) had PDLIM2 amplification (+1), 45 cases (47.4%) had heterozygous deletion (−1) and 4 cases (4.2%) had homozygous deletion (−2). The gene discussed is PDLIM2; the disease is esophageal squamous cell carcinoma.